Return to Homepage
Promoting Excellence in Education, Research, and Patient Care in the Rapidly Evolving Management of Gastrointestinal Cancer International Society of Gastrointestinal Oncology - Established 2003
About ISGIO Highlights/Newsletters Conferences Contact Us
2008 ISGIO Conference
Program Description
Invited Faculty
Scientific Program
Registration Information
Call for Abstracts
Educational Grants
ISGIO 2007 Meeting Information
2006 ISGIO Meeting Review
2005 ISGIO Meeting Review
Program Description
2008 Gastrointestinal Oncology Conference
Program Description

The 2008 Gastrointestinal Oncology Conference, the official meeting of the International Society of Gastrointestinal Oncology, will provide an educational forum for presenting and discussing the latest advances in the broad field of GI cancer research, as well as critical issues relevant to the care of persons with GI cancer.

The conference will feature distinguished speakers covering a broad spectrum of topics ranging from basic science to clinical therapeutics. Presenters and discussants will explore current issues and debate controversial topics. Case presentations will be given by the faculty and the audience will participate by an interactive audience response system to stimulate discussion on diagnosis and management. This program should be of interest to professionals actively engaged clinically or scientifically in all facets of GI cancer research and care.
 
Educational Objectives

After attending the Conference, participants will be able to:

Discuss current trends in therapy and therapeutic advances in research for various GI cancers.
Discuss current and new molecular biological pathways in GI cancers.
Better understand current trends in the therapy of colorectal cancer in the adjuvant and advanced settings.
Understand the latest techniques in therapeutic endoscopy and liver cancer ablation.
Determine when surgery is required in the management of localized esophageal cancer.
Discuss the role of surgery and chemoradiotherapy in the management of resectable gastric cancer.
Understand the role of radiotherapy in the management of pancreatic cancer.

Discuss the biology of Barrett’s metaplasia and its progression to carcinoma.

 
Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME).

 
Designation
This educational activity is designated for a maximum of 12.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
 
Nursing Continuing Education

This program is co-provided by the Boston College William F. Connell School of Nursing Continuing Education Program, Chestnut Hill, MA. This continuing education activity carries 12.5 contact hours. Participants must attend the entire educational activity for contact hours. Certificates will be mailed after completion of the program.

Boston College William F. Connell School of Nursing Continuing Education Program is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc. an accredited approver by the American Nurses Credentialing Centers Commission on Accreditation.
 
©2008 International Society of Gastrointestinal Oncology